218 related articles for article (PubMed ID: 19782051)
21. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
[TBL] [Abstract][Full Text] [Related]
22. Ca2+ influx-mediated dilation of the endoplasmic reticulum and c-FLIPL downregulation trigger CDDO-Me-induced apoptosis in breast cancer cells.
Jeong SA; Kim IY; Lee AR; Yoon MJ; Cho H; Lee JS; Choi KS
Oncotarget; 2015 Aug; 6(25):21173-92. PubMed ID: 26053096
[TBL] [Abstract][Full Text] [Related]
23. The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance.
Ikeda T; Sporn M; Honda T; Gribble GW; Kufe D
Cancer Res; 2003 Sep; 63(17):5551-8. PubMed ID: 14500394
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells.
Kim KB; Lotan R; Yue P; Sporn MB; Suh N; Gribble GW; Honda T; Wu GS; Hong WK; Sun SY
Mol Cancer Ther; 2002 Jan; 1(3):177-84. PubMed ID: 12467212
[TBL] [Abstract][Full Text] [Related]
25. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.
Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S
Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920
[TBL] [Abstract][Full Text] [Related]
26. c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells.
Zou W; Chen S; Liu X; Yue P; Sporn MB; Khuri FR; Sun SY
Cancer Biol Ther; 2007 Oct; 6(10):1614-20. PubMed ID: 18253090
[TBL] [Abstract][Full Text] [Related]
27. The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection.
Tran TA; McCoy MK; Sporn MB; Tansey MG
J Neuroinflammation; 2008 May; 5():14. PubMed ID: 18474101
[TBL] [Abstract][Full Text] [Related]
28. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells.
Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY
Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284
[TBL] [Abstract][Full Text] [Related]
29. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.
Wu T; Ye Y; Min SY; Zhu J; Khobahy E; Zhou J; Yan M; Hemachandran S; Pathak S; Zhou XJ; Andreeff M; Mohan C
Arthritis Rheumatol; 2014 Nov; 66(11):3129-39. PubMed ID: 25047252
[TBL] [Abstract][Full Text] [Related]
30. Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid.
Ikeda T; Nakata Y; Kimura F; Sato K; Anderson K; Motoyoshi K; Sporn M; Kufe D
Mol Cancer Ther; 2004 Jan; 3(1):39-45. PubMed ID: 14749474
[TBL] [Abstract][Full Text] [Related]
31. CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cells.
Kim EH; Deng CX; Sporn MB; Liby KT
Cancer Prev Res (Phila); 2011 Mar; 4(3):425-34. PubMed ID: 21372041
[TBL] [Abstract][Full Text] [Related]
32. Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5.
Akuetteh PDP; Huang H; Wu S; Zhou H; Jin G; Hong W; Yang H; Lan L; Shangguan F; Zhang Q
J Biochem Mol Toxicol; 2022 Nov; 36(11):e23192. PubMed ID: 35929395
[TBL] [Abstract][Full Text] [Related]
33. Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179.
Ahmad R; Raina D; Meyer C; Kharbanda S; Kufe D
J Biol Chem; 2006 Nov; 281(47):35764-9. PubMed ID: 16998237
[TBL] [Abstract][Full Text] [Related]
34. Prevention of Prostate Cancer with Oleanane Synthetic Triterpenoid CDDO-Me in the TRAMP Mouse Model of Prostate Cancer.
Gao X; Deeb D; Liu Y; Arbab AS; Divine GW; Dulchavsky SA; Gautam SC
Cancers (Basel); 2011; 3(3):3353-69. PubMed ID: 21961053
[TBL] [Abstract][Full Text] [Related]
35. CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma.
Gao X; Deeb D; Liu Y; Liu P; Zhang Y; Shaw J; Gautam SC
Int J Oncol; 2015 Dec; 47(6):2100-6. PubMed ID: 26497549
[TBL] [Abstract][Full Text] [Related]
36. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) potently enhances apoptosis induced by tumor necrosis factor in human leukemia cells.
Stadheim TA; Suh N; Ganju N; Sporn MB; Eastman A
J Biol Chem; 2002 May; 277(19):16448-55. PubMed ID: 11880365
[TBL] [Abstract][Full Text] [Related]
37. 2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer.
Samudio I; Konopleva M; Hail N; Shi YX; McQueen T; Hsu T; Evans R; Honda T; Gribble GW; Sporn M; Gilbert HF; Safe S; Andreeff M
J Biol Chem; 2005 Oct; 280(43):36273-82. PubMed ID: 16118208
[TBL] [Abstract][Full Text] [Related]
38. A novel mechanism of action of methyl-2-cyano-3,12 dioxoolean-1,9 diene-28-oate: direct permeabilization of the inner mitochondrial membrane to inhibit electron transport and induce apoptosis.
Samudio I; Konopleva M; Pelicano H; Huang P; Frolova O; Bornmann W; Ying Y; Evans R; Contractor R; Andreeff M
Mol Pharmacol; 2006 Apr; 69(4):1182-93. PubMed ID: 16410408
[TBL] [Abstract][Full Text] [Related]
39. Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation.
Zou W; Yue P; Khuri FR; Sun SY
Cancer Res; 2008 Sep; 68(18):7484-92. PubMed ID: 18794136
[TBL] [Abstract][Full Text] [Related]
40. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.
Duan Z; Ames RY; Ryan M; Hornicek FJ; Mankin H; Seiden MV
Cancer Chemother Pharmacol; 2009 Mar; 63(4):681-9. PubMed ID: 18587580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
